alexa Abstract | Mesenchymal Stem Cells As A Therapeutic Option For Patients With ALS
ISSN: 2327-5146

General Medicine: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review Open Access


It has been postulated that mesenchymal stem cells could play a role in treatment of patients with amyotrophic lateral sclerosis. Variety of mechanism behind MSC action has been proposed including immunomodulation and delivery of trophic factors. The scientific rationale in preclinical studies is being proved along with first clinical uses. Recent advances in stem cell research rises new hope for patients with ALS.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Dariusz Boruczkowski, Dominika Gładysz, Mariusz Grudniak, Karol Kosterna and Katarzyna Pawelec


General Medicine Doctor,Treatment and Diagnosis

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version